These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7545144)

  • 21. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
    Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
    Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
    Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients.
    Mroczko B; Szmitkowski M; Okulczyk B
    Clin Chem Lab Med; 2002 Apr; 40(4):351-5. PubMed ID: 12059074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum laminin is an independent prognostic factor in colorectal cancer.
    Saito N; Kameoka S
    Int J Colorectal Dis; 2005 May; 20(3):238-44. PubMed ID: 15592676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer.
    Basbug M; Arikanoglu Z; Bulbuller N; Cetinkaya Z; Aygen E; Akbulut S; Satici O
    Hepatogastroenterology; 2011; 58(106):400-5. PubMed ID: 21661403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.
    Emoto K; Yamada Y; Sawada H; Fujimoto H; Ueno M; Takayama T; Kamada K; Naito A; Hirao S; Nakajima Y
    Cancer; 2001 Sep; 92(6):1419-26. PubMed ID: 11745218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of colonoscopy on tumor markers.
    Scapa E; Broide E; Pinhasov I
    Surg Laparosc Endosc; 1997 Dec; 7(6):477-9. PubMed ID: 9438630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases.
    Dong H; Tang J; Li LH; Ge J; Chen X; Ding J; Men HT; Luo WX; Du Y; Li C; Zhao F; Chen Y; Cheng K; Liu JY
    Asian Pac J Cancer Prev; 2013; 14(2):909-13. PubMed ID: 23621260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour.
    Yoshida J; Wakabayashi T; Okamoto S; Kimura S; Washizu K; Kiyosawa K; Mokuno K
    J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1212-5. PubMed ID: 7523604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.
    Vukobrat-Bijedic Z; Husic-Selimovic A; Sofic A; Bijedic N; Bjelogrlic I; Gogov B; Mehmedovic A
    Med Arch; 2013 Dec; 67(6):397-401. PubMed ID: 25568506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.
    Kilic L; Yildiz I; Sen FK; Erdem MG; Serilmez M; Keskin S; Ciftci R; Karabulut S; Ordu C; Duranyildiz D; Tas F
    Cancer Biomark; 2015; 15(4):405-11. PubMed ID: 25792472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.
    Shim KS; Kim KH; Han WS; Park EB
    Cancer; 1999 Feb; 85(3):554-61. PubMed ID: 10091729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.
    Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Takemiya S; Yanoma S; Noguchi Y; Takanashi Y
    Br J Surg; 2001 Dec; 88(12):1596-601. PubMed ID: 11736971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.